1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Nexthera Capital Lp Buys UroGen Pharma, Amarin Corp PLC, Sarepta Therapeutics Inc, Sells Novartis AG, Heron Therapeutics Inc, Audentes Therapeutics Inc

Investment company Nexthera Capital Lp buys UroGen Pharma, Amarin Corp PLC, Sarepta Therapeutics Inc, uniQure NV, Neurocrine Biosciences Inc, Acorda Therapeutics Inc, Allergan PLC, Intercept Pharmaceuticals Inc, Kiniksa Pharmaceuticals, Sage Therapeutics Inc, Biomarin Pharmaceutical Inc, Madrigal Pharmaceuticals Inc, sells Novartis AG, Heron Therapeutics Inc, Audentes Therapeutics Inc, Bausch Health Inc, Immunomedics Inc, Horizon Therapeutics PLC, Insmed Inc, Global Blood Therapeutics Inc, Exelixis Inc, CymaBay Therapeutics Inc, Stemline Therapeutics Inc, Catalyst Biosciences Inc, Chiasma Inc, Zosano Pharma Corp, Deciphera Pharmaceuticals Inc, Athenex Inc, Osmotica Pharmaceuticals PLC, MediWound, Vaccinex Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Nexthera Capital Lp. As of 2019Q1, Nexthera Capital Lp owns 24 stocks with a total value of $82 million. These are the details of the buys and sells.

For the details of NEXTHERA CAPITAL LP's stock buys and sells, go to https://www.gurufocus.com/guru/nexthera+capital+lp/current-portfolio/portfolio

These are the top 5 holdings of NEXTHERA CAPITAL LP
  1. Audentes Therapeutics Inc (BOLD) - 250,620 shares, 11.87% of the total portfolio. Shares reduced by 67.2%
  2. Heron Therapeutics Inc (HRTX) - 388,623 shares, 11.53% of the total portfolio. Shares reduced by 52.56%
  3. Insmed Inc (INSM) - 284,263 shares, 10.03% of the total portfolio. Shares reduced by 66.12%
  4. Immunomedics Inc (IMMU) - 334,724 shares, 7.80% of the total portfolio. Shares reduced by 62.59%
  5. Bausch Health Companies Inc (BHC) - 205,660 shares, 6.16% of the total portfolio. Shares reduced by 69.07%
New Purchase: UroGen Pharma Ltd (URGN)

Nexthera Capital Lp initiated holding in UroGen Pharma Ltd. The purchase prices were between $35.47 and $54.55, with an estimated average price of $42.07. The stock is now traded at around $39.29. The impact to a portfolio due to this purchase was 5.94%. The holding were 132,589 shares as of .

New Purchase: Amarin Corp PLC (AMRN)

Nexthera Capital Lp initiated holding in Amarin Corp PLC. The purchase prices were between $12.61 and $22.33, with an estimated average price of $17.95. The stock is now traded at around $16.92. The impact to a portfolio due to this purchase was 3.75%. The holding were 148,695 shares as of .

New Purchase: Sarepta Therapeutics Inc (SRPT)

Nexthera Capital Lp initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $106.67 and $151.68, with an estimated average price of $128.32. The stock is now traded at around $119.19. The impact to a portfolio due to this purchase was 3.08%. The holding were 21,270 shares as of .

New Purchase: uniQure NV (QURE)

Nexthera Capital Lp initiated holding in uniQure NV. The purchase prices were between $27.39 and $68.41, with an estimated average price of $44.1. The stock is now traded at around $58.51. The impact to a portfolio due to this purchase was 2.81%. The holding were 38,800 shares as of .

New Purchase: Neurocrine Biosciences Inc (NBIX)

Nexthera Capital Lp initiated holding in Neurocrine Biosciences Inc. The purchase prices were between $69.31 and $91.53, with an estimated average price of $83.53. The stock is now traded at around $78.89. The impact to a portfolio due to this purchase was 2.57%. The holding were 24,040 shares as of .

New Purchase: Acorda Therapeutics Inc (ACOR)

Nexthera Capital Lp initiated holding in Acorda Therapeutics Inc. The purchase prices were between $12.93 and $17.47, with an estimated average price of $15.03. The stock is now traded at around $11.28. The impact to a portfolio due to this purchase was 2.5%. The holding were 154,806 shares as of .

Sold Out: Horizon Therapeutics PLC (HZNP)

Nexthera Capital Lp sold out a holding in Horizon Therapeutics PLC. The sale prices were between $19.49 and $29.01, with an estimated average price of $23.59.

Sold Out: Catalyst Biosciences Inc (CBIO)

Nexthera Capital Lp sold out a holding in Catalyst Biosciences Inc. The sale prices were between $7.67 and $9.96, with an estimated average price of $8.55.

Sold Out: Zosano Pharma Corp (ZSAN)

Nexthera Capital Lp sold out a holding in Zosano Pharma Corp. The sale prices were between $2.12 and $6, with an estimated average price of $3.44.

Sold Out: Athenex Inc (ATNX)

Nexthera Capital Lp sold out a holding in Athenex Inc. The sale prices were between $11.11 and $13.49, with an estimated average price of $12.2.

Sold Out: Osmotica Pharmaceuticals PLC (OSMT)

Nexthera Capital Lp sold out a holding in Osmotica Pharmaceuticals PLC. The sale prices were between $3.6 and $8.75, with an estimated average price of $7.39.

Sold Out: MediWound Ltd (MDWD)

Nexthera Capital Lp sold out a holding in MediWound Ltd. The sale prices were between $4.06 and $5.24, with an estimated average price of $4.79.



Here is the complete portfolio of NEXTHERA CAPITAL LP. Also check out:

1. NEXTHERA CAPITAL LP's Undervalued Stocks
2. NEXTHERA CAPITAL LP's Top Growth Companies, and
3. NEXTHERA CAPITAL LP's High Yield stocks
4. Stocks that NEXTHERA CAPITAL LP keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK